Peer-review started: January 30, 2014
First decision: March 19, 2014
Revised: November 16, 2014
Accepted: December 3, 2014
Article in press: January 4, 2015
Published online: January 26, 2015
Processing time: 359 Days and 2.6 Hours
In recent years attention has been raised to the fact of increased morbidity and mortality between women who suffer from coronary disease. The identification of the so called Yentl Syndrome has emerged the deeper investigation of the true incidence of coronary disease in women and its outcomes. In this review an effort has been undertaken to understand the interaction of coronary disease and female gender after the implementation of newer therapeutic interventional and pharmaceutics’ approaches of the modern era.
Core tip: Coronary disease although remains a leading cause of morbidity and mortality in women, is however underestimated mainly because of the protective role of estrogens that results in lower rates of the disease until the age of mid-fifty. In this review detailed information about the prevalence and the consequences of the disease in women are quoted as well as evidence concerning the results of invasive treatment and use of modern drug therapy.